In a normal response, sentinel pancreatic NK cells take on a regulatory phenotype after the initial phases of innate activation leading to effector status toward CD8+ T cells, thereby preventing β cell destruction and T1D. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.